SCHEMBL13654554

SCHEMBL13654554

Nc1nc(N[C@H]2C[C@H](N3CCCC3)C2)c2c(n1)C(c1ccccc1)CCC2

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 4/20 0.49
▸ HRH3 Q9Y5N1 4/20 0.49
▸ CCR4 P51679 1/20 0.37
▸ HRH2 P25021 1/20 0.37
▸ SIGMAR1 Q99720 2/20 0.36
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PSEN1 P49768 4/20 0.33
▸ PSEN2 P49810 4/20 0.33
▸ APH1B Q8WW43 4/20 0.33
▸ NCSTN Q92542 4/20 0.33
▸ APH1A Q96BI3 4/20 0.33
▸ PSENEN Q9NZ42 4/20 0.33
▸ EEF2K O00418 1/20 0.33
▸ LTA4H P09960 1/20 0.32
▸ MERTK Q12866 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13650570 0.92 HRH4 (0.49) HRH4HRH3CCR4HRH2SIGMAR1
SCHEMBL13650568 0.84 HRH3 (0.49) HRH4HRH3HRH2PSEN1PSEN2
SCHEMBL13650551 0.81 HRH3 (0.47) HRH4HRH3HRH2PSEN1PSEN2
SCHEMBL13650547 0.81 HRH3 (0.48) HRH4HRH3HRH2PSEN1PSEN2
SCHEMBL13650572 0.81 HRH3 (0.46) HRH4HRH3HRH2SIGMAR1CYP2D6
SCHEMBL13650550 0.81 HRH3 (0.46) HRH4HRH3HRH2PSEN1PSEN2
SCHEMBL13650569 0.78 HRH3 (0.47) HRH4HRH3HRH2SIGMAR1EEF2K
SCHEMBL13650553 0.78 HRH3 (0.46) HRH4HRH3HRH2PSEN1PSEN2
SCHEMBL13650508 0.78 HRH3 (0.68) HRH4HRH3CCR4HRH2CYP2D6
SCHEMBL13650500 0.78 HRH4 (0.65) HRH4HRH3HRH2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436005-B2 Macrocyclic pyrimidine derivatives ABBOTT LABORATORIES (US) 2013-05-07 — — US disclosed
WO-2009123967-A1 5,6,7,8-TETRAHYDROQUINAZOLIN-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ASTHMA ABBOTT LABORATORIES (US) 2009-10-08 — — WO disclosed
Send feedback